Cargando…

Coexistence of Metabolic Dysfunction‐Associated Fatty Liver Disease and Chronic Kidney Disease Is a More Potent Risk Factor for Ischemic Heart Disease

BACKGROUND: Metabolic dysfunction–associated fatty liver disease (MAFLD), defined as fatty liver with overweight/obesity, type 2 diabetes, or metabolic abnormalities, is a newly proposed disease. However, it remains unclear whether the coexistence of MAFLD and chronic kidney disease (CKD) is a more...

Descripción completa

Detalles Bibliográficos
Autores principales:	Miyamori, Daisuke, Tanaka, Marenao, Sato, Tatsuya, Endo, Keisuke, Mori, Kazuma, Mikami, Takuma, Hosaka, Itaru, Hanawa, Nagisa, Ohnishi, Hirofumi, Furuhashi, Masato
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2023
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10382120/ https://www.ncbi.nlm.nih.gov/pubmed/37421273 http://dx.doi.org/10.1161/JAHA.123.030269

Ejemplares similares

High fibrosis-4 index predicts the new onset of ischaemic heart disease during a 10-year period in a general population
por: Higashiura, Yukimura, et al.
Publicado: (2022)

Elevated Fatty Liver Index Is Independently Associated With New Onset of Hypertension During a 10‐Year Period in Both Male and Female Subjects
por: Higashiura, Yukimura, et al.
Publicado: (2021)

Increased LDL-cholesterol level is associated with deterioration of renal function in males
por: Osanami, Arata, et al.
Publicado: (2022)

Low urine pH predicts new onset of diabetes mellitus during a 10‐year period in men: BOREAS‐DM1 study
por: Higashiura, Yukimura, et al.
Publicado: (2020)

High level of fatty liver index predicts new onset of diabetes mellitus during a 10-year period in healthy subjects
por: Higashiura, Yukimura, et al.
Publicado: (2021)

Fatty liver index is independently associated with deterioration of renal function during a 10-year period in healthy subjects
por: Takahashi, Satoko, et al.
Publicado: (2021)

Reply to the comments of Naharci et al. on “Circulating level of fatty acid‐binding protein 4 is an independent predictor of metabolic dysfunction‐associated fatty liver disease in middle‐aged and elderly individuals”
por: Tanaka, Marenao, et al.
Publicado: (2022)

Circulating level of fatty acid‐binding protein 4 is an independent predictor of metabolic dysfunction‐associated fatty liver disease in middle‐aged and elderly individuals
por: Tanaka, Marenao, et al.
Publicado: (2022)

Plasma Tsukushi Concentration Is Associated with High Levels of Insulin and FGF21 and Low Level of Total Cholesterol in a General Population without Medication
por: Furuhashi, Masato, et al.
Publicado: (2022)

Circulating PCSK7 Level is Independently Associated with Obesity, Triglycerides Level and Fatty Liver Index in a General Population without Medication
por: Furuhashi, Masato, et al.
Publicado: (2022)

Fatty Acid-Binding Protein 4 (FABP4): Pathophysiological Insights and Potent Clinical Biomarker of Metabolic and Cardiovascular Diseases
por: Furuhashi, Masato, et al.
Publicado: (2015)

Independent links between plasma xanthine oxidoreductase activity and levels of adipokines
por: Furuhashi, Masato, et al.
Publicado: (2019)

Elevated circulating FABP4 concentration predicts cardiovascular death in a general population: a 12-year prospective study
por: Saito, Norie, et al.
Publicado: (2021)

Therapeutic strategy for the patients with coexisting gastroesophageal reflux disease and postprandial distress syndrome of functional dyspepsia
por: Isshi, Kimio, et al.
Publicado: (2020)

Serum Fatty Acid-Binding Protein 4 Is a Predictor of Cardiovascular Events in End-Stage Renal Disease
por: Furuhashi, Masato, et al.
Publicado: (2011)

Differential regulation of hypoxanthine and xanthine by obesity in a general population
por: Furuhashi, Masato, et al.
Publicado: (2020)

Insulin Resistance is Associated with Longitudinal Changes of Cardiac Repolarization Heterogeneity in Apparently Healthy Subjects
por: Matsumoto, Tamaki, et al.
Publicado: (2019)

Circulating Levels of Fatty Acid-Binding Protein Family and Metabolic Phenotype in the General Population
por: Ishimura, Shutaro, et al.
Publicado: (2013)

Urinary Excretion of Fatty Acid-Binding Protein 4 is Associated with Albuminuria and Renal Dysfunction
por: Okazaki, Yusuke, et al.
Publicado: (2014)

Serum FABP5 concentration is a potential biomarker for residual risk of atherosclerosis in relation to cholesterol efflux from macrophages
por: Furuhashi, Masato, et al.
Publicado: (2017)

Fatty Acid-Binding Protein 4 in Cardiovascular and Metabolic Diseases
por: Furuhashi, Masato
Publicado: (2019)

Antiatherosclerotic Phenotype of Perivascular Adipose Tissue Surrounding the Saphenous Vein in Coronary Artery Bypass Grafting
por: Mikami, Takuma, et al.
Publicado: (2021)

Significance of urinary fatty acid-binding protein 4 level as a possible biomarker for the identification of minimal change disease in patents with nephrotic-range proteinuria
por: Tanaka, Marenao, et al.
Publicado: (2020)

Prevalence of and risk factors for enlarged perivascular spaces in adult patients with moyamoya disease
por: Kuribara, Tomoyoshi, et al.
Publicado: (2017)

3D culture induction of adipogenic differentiation in 3T3-L1 preadipocytes exhibits adipocyte-specific molecular expression patterns and metabolic functions
por: Endo, Keisuke, et al.
Publicado: (2023)

Elevation of circulating fatty acid-binding protein 4 is independently associated with left ventricular diastolic dysfunction in a general population
por: Fuseya, Takahiro, et al.
Publicado: (2014)

Differential Phenotypes in Perivascular Adipose Tissue Surrounding the Internal Thoracic Artery and Diseased Coronary Artery
por: Numaguchi, Ryosuke, et al.
Publicado: (2019)

The coexistence of Darier’s disease and Hailey-Hailey disease symptoms
por: Tomaszewska, Katarzyna A., et al.
Publicado: (2017)

Coexistence of endocrinopathies in children with rheumatic diseases
por: Alhomaidah, Doha, et al.
Publicado: (2016)

Xanthomatous hypophysitis associated with autoimmune disease in an elderly patient: A rare case report
por: Oishi, Masahiro, et al.
Publicado: (2016)

Possible Increase in Serum FABP4 Level Despite Adiposity Reduction by Canagliflozin, an SGLT2 Inhibitor
por: Furuhashi, Masato, et al.
Publicado: (2016)

Ectopic Fatty Acid–Binding Protein 4 Expression in the Vascular Endothelium is Involved in Neointima Formation After Vascular Injury
por: Fuseya, Takahiro, et al.
Publicado: (2017)

IgG4-Related Disease coexisting with Behçet’s Disease
por: Alanazi, Mohammed B., et al.
Publicado: (2019)

Antiparkinsonian drugs as potent contributors to nocturnal sleep in patients with Parkinson’s disease
por: Taguchi, Soutarou, et al.
Publicado: (2021)

Association of serum creatinine-to-cystatin C ratio with skeletal muscle mass and strength in nonalcoholic fatty liver disease in the Iwaki Health Promotion Project
por: Mikami, Kenichiro, et al.
Publicado: (2022)

Coexistence of coeliac disease and type 1 diabetes
por: Szaflarska-Popławska, Anna
Publicado: (2014)

Moyamoya Disease with Coexistent Hypertriglyceridemia in Pediatric Patient
por: Chan, Jacqueline, et al.
Publicado: (2016)

Coexisting Diseases in Patients with Familial Mediterranean Fever
por: Salehzadeh, Farhad, et al.
Publicado: (2020)

Coexistence of Peripheral Retinal Diseases with Macular Hole
por: Yaşar, Erdoğan, et al.
Publicado: (2019)

Coronavirus Disease 2019 Coexistence in the Daily Practice
por: Tallarico, Marco, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_8gjqb1kdc226r7nooamgqjnsm4